When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics.
So its maker, Forest Laboratories, launched a promotional assault on the group in the best position to determine Bystolic's success: those in control of prescription pads. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors.
Who's going to be more successful at selling health insurance to young men this fall: NBA MVP LeBron James, NFL rookie of the year Robert Griffin III, or Mom? If officials at the Department of Health and Human Services get their way, all may be drafted.
Children often get sinus infections after they've had a cold.
It can be hard for parents and doctors to tell when those infections need treatment with antibiotics, and when they should be left to get better on their own.
The nation's pediatricians are trying to make that call a bit easier. In new guidelines released today, they say that it's OK to wait a while longer to see if a child gets better before treating a sinus infection with antibiotics. Now parents can wait and see what happens for 13 days instead of 10 days, the pediatricians recommend.
The nation's organ transplant network will consider a controversial proposal Monday to overhaul the guidelines for an increasingly common form of organ donation.
The board of directors of the United Network for Organ Sharing will open a two-day meeting at the organization's headquarters in Richmond, Va., to consider new guidelines for donation after cardiac death.
Donation after cardiac death involves removing organs minutes after life-support has been stopped for patients who still have at least some brain activity.